Shows & Panels
- AFCEA Answers
- Ask the CIO
- The Big Data Dilemma
- Carrying On with Continuity of Operations
- Connected Government
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Cyber Imperative
- Cyber Solutions for 2013 and Beyond
- Expert Voices
- Federal Executive Forum
- Federal IT Challenge
- Federal Tech Talk
- Mission-critical Apps in the Cloud
- The Path from Legacy Systems
- The Real Deal on Digital Government
- The Reality of Continuous Monitoring... Is Your Agency Secure?
- Veterans in Private Sector: Making the Transition
Shows & Panels
News Summary: Fast-growing salmon in FDA limbo
Tuesday - 12/4/2012, 5:22pm EST
(AP) - STAYING AFLOAT: A Massachusetts biotech firm that was poised to become the first company to sell a genetically-modified fish says it may run out of money before regulators approve its fast-growing salmon.
FRANKENFISH: Aquabounty's Atlantic salmon contains an extra hormone that makes it to grow twice as fast as a traditional salmon. Despite concerns from environmentalists, regulators said in 2010 that the fish appeared safe to eat.
RUNNING ON EMPTY: The Food and Drug Administration says it is still working to complete its review of Aquabounty's salmon. Company executives say they only have enough money to operate the company until January.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)